Mark P. Fitzgerald, MD, PhD Mark P. Fitzgerald, MD, PhD, is a pediatric neurologist in the Division of Neurology and Associate Medical Director of the Neurophysiology Lab at Children's Hospital of Philadelphia. Areas of Expertise: Neonatal and early life epilepsies, Genetic epilepsy Locations: Main Campus; Specialty Care & Surgery Center, King of Prussia Appointments and Referrals: 1-800-TRY-CHOP (1-800-879-2467) Education and Training Medical SchoolMD - University of Virginia, Charlottesville, VA ResidencyChild Neurology - Children's Hospital of Philadelphia, Philadelphia, PA Pediatrics - Children's Hospital of Philadelphia, Philadelphia, PA FellowshipEpilepsy and Clinical Neurophysiology, Children’s Hospital of Philadelphia, Philadelphia, PA Board CertificationChild NeurologyNeurologyGraduate DegreePhD in Neuroscience - University of Virginia, Charlottesville, VA Titles and Academic Titles Attending PhysicianAssociate Medical Director, Neurophysiology LabAssistant Professor of Neurology, Perelman School of Medicine at the University of Pennsylvania Departments and Services Division of NeurologyPediatric Epilepsy Program Publications Papers2017 Fitzgerald MP, Kessler SK, and Abend NS. Early discontinuation of anti-seizure medications in neonates with hypoxic-ischemic encephalopathy. Epilepsia. 2017 Jun;58(6):1047-1053. doi: 10.1111/epi.13745. Epub 2017 Apr 12. Fitzgerald MP and Ryan N. An updated, evidence-based clinician’s guide to the evaluation and treatment of West syndrome. Curr Pediatr Rep. DOI: 10.1007/s40124-017-0123-x. 2015 Sharma S, Lerman M, Fitzgerald MP, and Ruebner R. Acute psychosis presenting in a patient with systemic lupus erythematosus: Questions & Answers. Pediatr Nephrol. 2016 Feb;31(2):227-31. doi: 10.1007/s00467-015-3052-3. Epub 2015 Jan 30. 2011 Fitzgerald MP, Covio M, and Lee KS. (2011). Disturbances in the positioning, proliferation, and apoptosis of neural progenitors contribute to subcortical band heterotopia formation. Neuroscience. 2011 Mar 10;176:455-71. doi: 10.1016/j.neuroscience.2010.12.003. Epub 2010 Dec 9. Abstracts2016 Fitzgerald MP, Kessler SK, and Abend NS. (2016). Early discontinuation of anti-seizure medications in neonates with hypoxic-ischemic encephalopathy. American Epilepsy Society. Houston, TX. Barcikowski J, Fitzgerald MP, Jaffe A, and Mowery D. (2016). Unexpected Transverse Myelitis after Dinutuximab Therapy for Relapsed Neuroblastoma: A Case Report. AAPM&R Annual Assembly. New Orleans, LA. Fitzgerald MP, Massey SL, Kessler SK, Flibotte J, Dlugos D, Abend NS. (2016). Seizures and developmental outcomes in neonates with HIE. American Clinical Neurophysiology Society. Orlando, FL. Fitzgerald MP, Massey SL, Kessler SK, Flibotte J, Dlugos D, Abend NS. (2016). Seizure recurrence risk in neonates treated with hypothermia for HIE. American Clinical Neurophysiology Society. Orlando, FL. Books2009 Trotter SA, Fitzgerald MP, Lee KS. The tish rat: an animal model of cortical malformation in the study of epilepsy. In: Schwartzkroin PA, editor. Encyclopedia of Basic Epilepsy Research. Oxford: Elsevier; 2009. Calisaneller T, Lin C-L, Ukita N, Yoshimura R, Wang Y, Fitzgerald MP, and Lee KS. A blood injection model of subarachnoid hemorrhage in the mouse. In: Chen J, XuX, Xu ZC, Zhang J, editors. Animal Models of Acute Neurological Injuries. New Jersey: Humana Press; 2009. Posters and Presentations2017 Fitzgerald MP. Early Discontinuation of Anti-seizure Medications in Neonates with Hypoxic-Ischemic Encephalopathy. Presented at: Neonatal SIG, American Epilepsy Society Annual Meeting; 2017 Dec; Houston TX. Fitzgerald MP. KCNT1-related Epilepsy: The Quinidine Story. Presented at: American Epilepsy Society Annual Meeting, Dec. 2017, Washington, D.C. Fitzgerald MP, Massey SL, Fung F, Kessler SK, Abend NS. Seizures and developmental outcomes in neonates with HIE. American Epilepsy Society Annual Meeting, Dec. 2017, Washington, D.C. Fitzgerald MP, Smith DM, Moller RS, Fiannacca M, McGinnis E, Gunning B, Rubboli G, Syrbe S, Brilstra E, Picard F, Stamberger H, Weckhuysen S, Striano P, Baglietto MG, Verbeek NE, Barolomei F, Lesca G, Maurey H, Nava C, Hirsch E, Baulac S, Ceulemans B, Schoonjans AS, Helbig I, Dlugos D, and Bearden D. Response to treatment in patients with KCNT1-related epilepsy. American Epilepsy Society Annual Meeting, Dec. 2017, Washington, D.C. Massey S, Clancy R, Digiovine M, Fitzgerald MP, Fung F, Shou H, Farrar J, Abend N. Inter-rater agreement in neonatal electroencephalogram background scoring. American Epilepsy Society Annual Meeting, Dec. 2017, Washington, D.C. Abend NS, Massey S, Fitzgerald MP, Fung F, Atkin NJ, Xiao R, Topjian AA. Interrater variability of EEG interpretation after pediatric cardiac arrest utilizing standardized critical care EEG terminology. American Epilepsy Society Annual Meeting, Dec. 2017, Washington, D.C. 2015 Fitzgerald MP. Status Epilepticus. Presented at: Clinical Neuroscience Conference, Children’s Hospital of Philadelphia; 2015 Jul; Philadelphia, PA. Fitzgerald MP. Dravet Syndrome: The (In)complete Story. Presented at: Clinical Neuroscience Conference, Children’s Hospital of Philadelphia; 2015 Feb; Philadelphia, PA. Awards and Honors 2009, Eric W. Lothman Award for Outstanding Scholarly Achievement in Neuroscience, University of Virginia 2002, Who’s Who Among Students in American Colleges and Universities 2002, Lawrence J. Lennon Award for Outstanding Service and Achievement in Psychology, University of Scranton 2002, Excellence in Psychology Award, University of Scranton 2002, Excellence in Neuroscience Award, University of Scranton Editorial and Academic Positions Academic and Institutional Committees 2015-present, ICU Neurology Advisory Committee, Children’s Hospital of Philadelphia Leadership and Memberships 2015-present, American Epilepsy Society Member 2013-present, American Academy of Neurology Member Patient Experience Ratings About the Patient Experience Rating System The Patient Experience Rating is an average of all responses to the care provider related questions shown above from our nationally-recognized Press Ganey Patient Satisfaction Survey. Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question. Responses are measured on a scale of 1 to 5 with 5 being the best score. We are committed to true transparency. However, to ensure the comments are fair and correctly attributed, we review each one before posting to the website. We exclude entire comments that disclose patient's protected health information, are off-topic, or include other confidential or inappropriate content. Comments will appear on provider bios only if providers have a minimum number of comments. Comments are shared internally for education purposes to ensure that we are doing our very best for the patients and families for whom we are privileged to care. The comments are submitted by patients and families and reflect their views and opinions. The comments are not endorsed by and do not reflect the views of Children’s Hospital of Philadelphia.